0001104659-21-077205.txt : 20210604
0001104659-21-077205.hdr.sgml : 20210604
20210604175019
ACCESSION NUMBER: 0001104659-21-077205
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210602
FILED AS OF DATE: 20210604
DATE AS OF CHANGE: 20210604
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CORRIGAN MARK
CENTRAL INDEX KEY: 0001250661
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37558
FILM NUMBER: 21997649
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nabriva Therapeutics plc
CENTRAL INDEX KEY: 0001641640
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 56 FITZWILLIAM SQUARE
CITY: DUBLIN
STATE: L2
ZIP: 2
BUSINESS PHONE: (610) 816-6640
MAIL ADDRESS:
STREET 1: 1000 CONTINENTAL DRIVE
STREET 2: SUITE 600
CITY: KING OF PRUSSIA
STATE: PA
ZIP: 19406
FORMER COMPANY:
FORMER CONFORMED NAME: Nabriva Therapeutics AG
DATE OF NAME CHANGE: 20150507
4
1
tm2118134-5_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-06-02
0
0001641640
Nabriva Therapeutics plc
NBRV
0001250661
CORRIGAN MARK
414 COMMERCE DR.
SUITE 120
FORT WASHINGTON
PA
19034
1
0
0
0
Share Options
1.39
2021-06-02
4
A
0
10500
0
A
2031-06-01
Ordinary Shares
10500
10500
D
The option was granted on June 2, 2021.
The option will vest over a three-year period on a monthly pro rata basis beginning on June 2, 2021 and subject to the Reporting Person's continued service on the board of directors of the Issuer.
/s/ Robert Crotty, by power of attorney
2021-06-04